Lauren Iarrobino
Adult Health · Commack, NYNPI 1710362728
Payments from drug & device makers
Across 77 payments — averaging $24.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$642
- Novo Nordisk$245
- Exact Sciences$127
- Lilly USA, LLC$115
- Pfizer$83
- Merck$80
- plus $575 from 21 others
What the payments were for
- Food & beverage$1,867100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 14 | $642 |
| Novo Nordisk | 15 | $245 |
| Exact Sciences | 5 | $127 |
| Lilly USA, LLC | 5 | $115 |
| Pfizer | 5 | $83 |
| Merck | 4 | $80 |
| Daiichi Sankyo Inc. | 3 | $68 |
| Novartis | 3 | $53 |
| Astellas Pharma US Inc | 2 | $50 |
| Bayer | 2 | $49 |
| GSK | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Corcept Therapeutics | 2 | $31 |
| Seqirus USA Inc | 1 | $27 |
| Sanofi | 1 | $26 |
| Dexcom, Inc. | 1 | $23 |
| Procept Biorobotics Corporation | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Abbott | 1 | $19 |
| Phadia US Inc. | 1 | $18 |
| AbbVie | 1 | $18 |
| 3b Medical, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Alk-abello, Inc | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Philips North America LLC | 1 | $13 |
| Vistapharm, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,867 in reported general payments places this provider in the 80th percentile of 3,828 adult health providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 58 | $631 |
| Metoprolol Succinate | 22 | $571 |
| Atorvastatin Calcium | 78 | $451 |
| Rosuvastatin Calcium | 39 | $336 |
| Losartan Potassium | 30 | $279 |
| Amlodipine Besylate | 43 | $126 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $112 |
| Metformin Hcl | 24 | $79 |
| Azithromycin | 13 | $44 |
| Prednisone | 11 | $18 |
Paid to pharmacies, not to this prescriber.
Other adult health in Commack
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Katelyn McCormackAmherst$201K
- Mary CiechoskiBuffalo$200K
- Patricia LorussoLancaster$161K
- Jennifer FioriniGlens Falls$151K
- Tia AlbroRochester$142K
- Maria Gigante-BaggettEast Syracuse$92K
- Jane PattersonRochester$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.